Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-23
DOI
10.1038/s41375-020-0927-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic interaction networks in cancer cells
- (2019) Barbara Mair et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
- (2019) Evisa Gjini et al. Disease Models & Mechanisms
- Targeting epigenetics using synthetic lethality in precision medicine
- (2018) Ee Sin Chen CELLULAR AND MOLECULAR LIFE SCIENCES
- Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?
- (2018) Narjust Duma et al. Current Oncology Reports
- TET2 in Normal and Malignant Hematopoiesis
- (2017) Robert L. Bowman et al. Cold Spring Harbor Perspectives in Medicine
- PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment
- (2016) Lu Zhao et al. EXPERIMENTAL HEMATOLOGY
- DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
- (2016) Hanae Sato et al. Frontiers in Oncology
- Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
- (2015) J.-S. Ahn et al. HAEMATOLOGICA
- PARP inhibitors: a treatment option for AML?
- (2015) Lan Wang et al. NATURE MEDICINE
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute loss of TET function results in aggressive myeloid cancer in mice
- (2015) Jungeun An et al. Nature Communications
- Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
- (2015) J.-S. Ahn et al. HAEMATOLOGICA
- TET2as an epigenetic master regulator for normal and malignant hematopoiesis
- (2014) Hideaki Nakajima et al. CANCER SCIENCE
- Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis
- (2014) Wen-Jian Liu et al. LEUKEMIA & LYMPHOMA
- A Zebrafish Model of Myelodysplastic Syndrome Produced throughtet2Genomic Editing
- (2014) Evisa Gjini et al. MOLECULAR AND CELLULAR BIOLOGY
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- PARP1–TDP1 coupling for the repair of topoisomerase I–induced DNA damage
- (2014) Benu Brata Das et al. NUCLEIC ACIDS RESEARCH
- Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel
- (2013) Rui Gao et al. DNA REPAIR
- Efficient Gene Targeting in Zebrafish Mediated by a Zebrafish-Codon-Optimized Cas9 and Evaluation of Off-Targeting Effect
- (2013) Da Liu et al. Journal of Genetics and Genomics
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- (2013) Woong Y Hwang et al. NATURE BIOTECHNOLOGY
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia
- (2012) S Wakita et al. LEUKEMIA
- TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
- (2011) W.-C. Chou et al. BLOOD
- Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
- (2011) D C Gilbert et al. BRITISH JOURNAL OF CANCER
- Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish
- (2010) N. Bolli et al. BLOOD
- Hematopoietic Stem Cell Development Is Dependent on Blood Flow
- (2009) Trista E. North et al. CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started